Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manon van Engeland

Showing results (71-80 of 139) with videos related to

Pageof 14
Sort By:
Carcinogenesis|December 1, 2007
Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterationsSarah Derks, Cindy Postma, Beatriz Carvalho, et al.
Molecular Cancer Therapeutics|March 1, 2006
Angiostatic activity of DNA methyltransferase inhibitorsDebby M E I Hellebrekers, Kam-Wing Jair, Emmanuelle Viré, et al.
The Journal of Investigative Dermatology|July 8, 2014
Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancyLinda Gao, Karin van den Hurk, Peter T M Moerkerk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2005
Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumorsNathalie L G Sieben, Jan Oosting, Adrienne M Flanagan, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|September 18, 2009
Different angiogenic potential in low and high grade sporadic clear cell renal cell carcinoma is not related to alterations in the von Hippel-Lindau geneMarcella M Baldewijns, Iris J H van Vlodrop, Kim M Smits, et al.
Plos One|August 21, 2008
Lamin A/C is a risk biomarker in colorectal cancerNaomi D Willis, Thomas R Cox, Syed F Rahman-Casañs, et al.
Histopathology|August 25, 2019
SOX17 expression and its down-regulation by promoter methylation in cervical adenocarcinoma in situ and adenocarcinomaAnton N H Hopman, Jobran M Moshi, Klaas J Hoogduin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 27, 2013
MEN1 gene mutation and reduced expression are associated with poor prognosis in pulmonary carcinoidsDorian R A Swarts, Aldo Scarpa, Vincenzo Corbo, et al.
The Journal of Nutrition|August 22, 2007
Folic acid and vitamin B-12 supplementation does not favorably influence uracil incorporation and promoter methylation in rectal mucosa DNA of subjects with previous colorectal adenomasMaureen van den Donk, Linette Pellis, Jimmy W Crott, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 14, 2011
Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomasCarolina A J Khalid-de Bakker, Daisy M A E Jonkers, Silvia Sanduleanu, et al.
Pageof 14

Showing results (71-80 of 139) with videos related to

Sort By:
Pageof 14
Carcinogenesis|December 1, 2007
Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterationsSarah Derks, Cindy Postma, Beatriz Carvalho, et al.
Molecular Cancer Therapeutics|March 1, 2006
Angiostatic activity of DNA methyltransferase inhibitorsDebby M E I Hellebrekers, Kam-Wing Jair, Emmanuelle Viré, et al.
The Journal of Investigative Dermatology|July 8, 2014
Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancyLinda Gao, Karin van den Hurk, Peter T M Moerkerk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2005
Differential gene expression in ovarian tumors reveals Dusp 4 and Serpina 5 as key regulators for benign behavior of serous borderline tumorsNathalie L G Sieben, Jan Oosting, Adrienne M Flanagan, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|September 18, 2009
Different angiogenic potential in low and high grade sporadic clear cell renal cell carcinoma is not related to alterations in the von Hippel-Lindau geneMarcella M Baldewijns, Iris J H van Vlodrop, Kim M Smits, et al.
Plos One|August 21, 2008
Lamin A/C is a risk biomarker in colorectal cancerNaomi D Willis, Thomas R Cox, Syed F Rahman-Casañs, et al.
Histopathology|August 25, 2019
SOX17 expression and its down-regulation by promoter methylation in cervical adenocarcinoma in situ and adenocarcinomaAnton N H Hopman, Jobran M Moshi, Klaas J Hoogduin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 27, 2013
MEN1 gene mutation and reduced expression are associated with poor prognosis in pulmonary carcinoidsDorian R A Swarts, Aldo Scarpa, Vincenzo Corbo, et al.
The Journal of Nutrition|August 22, 2007
Folic acid and vitamin B-12 supplementation does not favorably influence uracil incorporation and promoter methylation in rectal mucosa DNA of subjects with previous colorectal adenomasMaureen van den Donk, Linette Pellis, Jimmy W Crott, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 14, 2011
Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomasCarolina A J Khalid-de Bakker, Daisy M A E Jonkers, Silvia Sanduleanu, et al.
Pageof 14